Morepen Laboratories Limited (BSE: 500288)
Health Care · Pharmaceuticals · IN
Rs96.00
+13.99% today · +95.8% 1Y
Morepen Laboratories Limited (BSE: 500288) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $549.79M.
Over the last twelve months the share price has gained 95.8%, trading between 33.44 and 97.46.
Tweenvest scores Morepen Laboratories Limited across four factors: quality 68/100, value 28/100, growth 55/100, dividend 42/100. Its strongest factor is quality.
500288 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $549.79M
- Revenue (TTM)
- $206.30M
- P/E
- 37.64
- EPS
- 2.55
- Dividend yield
- 0.21%
- Beta (5Y)
- 0.77
- 52-week high
- Rs97.46
- 52-week low
- Rs33.44
- Avg volume (3M)
- —
- Shares outstanding
- 547.95M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.